within Pharmacolibrary.Drugs.ATC.S;

model S01AA12
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 2.1 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 80 / 1000000,
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Tobramycin is an aminoglycoside antibiotic primarily used to treat serious bacterial infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa. It is commonly used in ophthalmic formulations and is approved for both systemic and topical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Dhanani, JA, et al., &amp; Fraser, JF (2019). Lung Pharmacokinetics of Tobramycin by Intravenous and Nebulized Dosing in a Mechanically Ventilated Healthy Ovine Model. <i>Anesthesiology</i> 131(2) 344–355. DOI:<a href=&quot;https://doi.org/10.1097/ALN.0000000000002752&quot;>10.1097/ALN.0000000000002752</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31107274/&quot;>https://pubmed.ncbi.nlm.nih.gov/31107274</a></p></li><li><p>Kruizinga, MD, et al., &amp; Zuiker, RGJA (2020). Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for pharmacokinetic analysis. <i>British journal of clinical pharmacology</i> 86(1) 175–181. DOI:<a href=&quot;https://doi.org/10.1111/bcp.14156&quot;>10.1111/bcp.14156</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31658494/&quot;>https://pubmed.ncbi.nlm.nih.gov/31658494</a></p></li><li><p>Germovsek, E, et al., &amp; Sharland, M (2017). What do I need to know about aminoglycoside antibiotics?. <i>Archives of disease in childhood. Education and practice edition</i> 102(2) 89–93. DOI:<a href=&quot;https://doi.org/10.1136/archdischild-2015-309069&quot;>10.1136/archdischild-2015-309069</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27506599/&quot;>https://pubmed.ncbi.nlm.nih.gov/27506599</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01AA12;
